| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |